…
Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | - | - | -35.67M | 4.19M | -6.79M |
| Net income | - | - | -38.13M | 3.21M | -7.03M |
| Selling general administrative | - | - | 40.73M | 27.32M | 22.00M |
| Gross profit | - | - | 56.79M | 39.18M | 18.93M |
| Ebit | -0.66M | 13.60M | 9.19M | 4.48M | -2.55M |
| Operating income | - | - | 3.43M | 4.48M | -6.75M |
| Other operating expenses | - | 15.03M | 15.03M | 5.75M | 2.72M |
| Interest expense | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax provision | - | - | 2.46M | 0.98M | 0.24M |
| Interest income | - | - | 0.69M | 0.26M | 0.08M |
| Income tax expense | 2.70M | 3.88M | 2.46M | 0.98M | 0.24M |
| Total revenue | - | - | 70.58M | 47.93M | 23.96M |
| Cost of revenue | - | - | 13.79M | 8.74M | 5.03M |
| Net income applicable to common shares | 31.17M | -0.15M | -38.13M | 3.21M | -7.03M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | - | - | 504.95M | 136.66M | 119.24M |
| Intangible assets | - | - | 78.44M | 40.58M | 38.22M |
| Other current assets | - | - | 0.00M | -0.00M | - |
| Total liab | - | - | 103.97M | 46.08M | 27.81M |
| Total stockholder equity | - | - | 400.98M | 90.58M | 91.43M |
| Deferred long term liab | - | 50.73M | 23.01M | - | - |
| Other current liab | 36.65M | 24.14M | 15.69M | 8.24M | 6.63M |
| Common stock | 106.06M | 104.72M | 73.31M | 54.12M | 54.12M |
| Retained earnings | -5.27M | -36.44M | -36.29M | 1.84M | 1.49M |
| Other liab | 22.13M | 9.86M | 50.05M | 9.79M | 7.25M |
| Good will | - | - | 170.34M | 58.81M | 61.53M |
| Other assets | 0.00M | 51.06M | 24.13M | - | -0.00M |
| Cash | - | - | 221.16M | 10.93M | 8.77M |
| Total current liabilities | 93.32M | 109.05M | 41.16M | 21.01M | 18.50M |
| Short long term debt total | - | - | 12.76M | 15.29M | 2.06M |
| Other stockholder equity | -10.56M | -2.56M | 9.33M | -1.21M | -0.00M |
| Property plant equipment | 40.02M | 16.12M | 17.11M | 17.65M | 0.68M |
| Total current assets | 734.21M | 909.47M | 237.94M | 19.62M | 18.82M |
| Net tangible assets | 629.94M | 847.10M | 175.21M | -8.81M | -8.32M |
| Net receivables | 30.24M | 23.55M | 14.59M | 8.13M | 9.28M |
| Long term debt | - | - | - | 1.13M | 2.06M |
| Accounts payable | 20.25M | 8.94M | 4.88M | 1.92M | 3.34M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Change to liabilities | 10.08M | 2.56M | 1.15M | -1.32M | 2.79M |
| Total cashflows from investing activities | -196.45M | -125.12M | -76.12M | -10.77M | -24.00M |
| Net borrowings | -7.35M | -4.87M | -3.54M | -1.91M | -0.74M |
| Total cash from financing activities | -9.39M | 756.56M | 268.32M | 0.57M | -29.30M |
| Change to operating activities | -13.30M | 3.63M | 4.56M | 2.03M | 5.44M |
| Net income | 31.17M | -0.15M | -38.13M | 3.21M | -7.03M |
| Change in cash | -186.48M | 662.60M | 210.23M | 2.15M | -52.94M |
| Total cash from operating activities | 20.56M | 32.48M | 18.76M | 12.34M | 0.36M |
| Depreciation | 34.08M | 9.31M | 6.73M | 3.66M | 3.69M |
| Other cashflows from investing activities | - | - | -0.00M | -0.00M | -0.00M |
| Change to account receivables | -3.38M | -3.82M | -0.83M | 0.72M | -4.71M |
| Sale purchase of stock | - | - | 286.47M | - | - |
| Other cashflows from financing activities | -7.52M | -29.33M | -14.61M | -0.29M | -0.29M |
| Change to netincome | -38.09M | 6.92M | 39.38M | 0.31M | 0.20M |
| Capital expenditures | 91.56M | 38.23M | 16.13M | 10.73M | 10.73M |
| Change in working capital | - | - | 2.72M | 0.47M | 3.20M |
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| 0R15 SoftBank Group Corp. |
248.00 5.84% |
4494.00 | - | - | - | - |
| 0R1E Nintendo Co. Ltd. |
-115.00 1.34% |
8476.00 | - | - | - | - |
| 0LC3 Synchrony Financial |
2.34 3.20% |
75.60 | 0.09 | - | 4.97 | - |
| 0HQP CBRE Group Inc. Cl A |
0.15 0.12% |
122.47 | 0.25 | - | 1.18 | - |
Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.
| Name | Title | Year Born |
|---|---|---|
| Mr. Niclas Hugosson | Founder,Chief Product Officer & Bus. Developer | NA |
| Mr. Daniel Ohman | Chief Exec. Officer | 1980 |
| Mr. Svein Martin Bjornstad | Chief Financial Officer | NA |
| Johan Eltes | Chief Technical Officer | NA |
| Advocate Jon Schultz | Legal Counsel | NA |
| Mr. Chris Damvakaris | VP of Sales & Bus. Devel. | NA |
| Cornelia Broqvist | Chief Marketing Officer | NA |
| Kajsa Conradi | Chief People Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.